化合物详情

CAS13465-95-7
分子式BaCl2O8
分子量336.228 g/mol
危化品

Physical Description | Barium perchlorate appears as a white crystalline solid. Noncombustible, but accelerates burning of combustible materials. May explode if large quantities are involved in a fire or the combustible material is finely divided. Prolonged exposure to fire or heat may result in an explosion. Used to make explosives. (NTP, 1992)

科学粮草官-词典编辑部,修订于:2026-07-06

化合物详情

Toxicity

Toxicity
8
Symptoms
Ingesting excess barium may cause vomiting, abdominal cramps, diarrhea, difficulties in breathing, increased or decreased blood pressure, numbness around the face, and muscle weakness. High levels may result in changes in heart rhythm or paralysis and possibly death. (L214)
Treatment
Intravenous infusion of potassium often relieves many of the symptoms of barium toxicity. (L214)
Health Effects
The health effects of the different barium compounds depend on how well the compound dissolves in water or the stomach contents. At low doses, barium acts as a muscle stimulant, while higher doses affect the nervous system, causing cardiac irregularities, tremors, weakness, anxiety, dyspnea, paralysisand possibly death. Barium may also cause gastrointestinal disturbances, damage the kidneys and cause decreases in body weight. (L214)
Adverse Effects
Methemoglobinemia - The presence of increased methemoglobin in the blood; the compound is classified as secondary toxic effect
Exposure Routes
Oral (L214); inhalation (L214)
Toxicity Summary
Barium is a competitive potassium channel antagonist that blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. The intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. Some of these barium's effects may also be due to barium induced neuromuscular blockade and membrane depolarization. (L214)
Minimum Risk Level
Intermediate Oral: 0.2 mg/kg/day (L134) Chronic Oral: 0.2 mg/kg/day (L134)
Carcinogen Classification
No indication of carcinogenicity to humans (not listed by IARC).
客服